Long term results of a randomized study performed by Intergruppo Italiano Linfomi comparing Mini-CEOP vs P-VEBEC in elderly patients with diffuse large B-cell lymphoma-Reference-Cited by-同舟云学术

Long term results of a randomized study performed by Intergruppo Italiano Linfomi comparing Mini-CEOP vs P-VEBEC in elderly patients with diffuse large B-cell lymphoma

Published:2007-01 Issue:2 Volume:48 Page:367-373
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Merli F.,Bertini M.,Luminari S.,Mozzana R.,Botto B.,Liberati A. M.,Baldini L.,Cabras G.,Di Vito F.,Orsucci L.,Naglieri E.,Polimeno G.,Marcheselli L.,Pennese E.,Vitolo U.,Federico M.,Gallo E.

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

http://www.tandfonline.com/doi/pdf/10.1080/10428190601078100

Reference24 articles.

1. The importance of age in survival of patients treated with chemotherapy for aggressive non-Hodgkin's lymphoma.

2. Low-dose ACOP-B and VABE: weekly chemotherapy for elderly patients with advanced-stage diffuse large-cell lymphoma.

3. A prospective study of a new combination chemotherapy regimen in patients older than 70 years with unfavorable non-Hodgkin's lymphoma.

4. P-VABEC: a prospective study of a new weekly chemotherapy regimen for elderly aggressive non-Hodgkin's lymphoma.

5. Treatment and Clinical Management of Primary Mediastinal Large B-Cell Lymphoma With Sclerosis: MACOP-B Regimen and Mediastinal Radiotherapy Monitored by 67Gallium Scan in 50 Patients

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diffuse Large B-Cell Lymphoma in the Elderly: Current Approaches;Current Oncology Reports;2020-08-22

2. Outcome of patients older than 80 years with diffuse large B-cell lymphoma (DLBCL) treated with “standard” immunochemotherapy: A large retrospective study from 4 institutions;Hematological Oncology;2017-06-16

3. Assessment of Correlation Between Early and Late Efficacy Endpoints to Identify Potential Surrogacy Relationships in Non-Hodgkin Lymphoma: a Literature-Based Meta-analysis of 108 Phase II and Phase III Studies;The AAPS Journal;2017-02-21

4. Risk of chemotherapy-induced neutropenic complications when treating patients with non-Hodgkin lymphoma;Expert Opinion on Drug Safety;2016-03-11

5. Desenlaces clínicos en hematoncología: diez años de investigaciones en Pubmed;Revista Colombiana de Cancerología;2015-04